In vitro culture and characterization of oligodendrocyte precursor cells derived from neonatal rats

Neurological Research

Volumn 33, Issue 6, 2011, Pages 593-599

  Wu, Bo ^a,b   Guo, Shuzhang ^b   Jiang, Tao ^b   Ren, Xianjun ^b  

^a 88th Hospital   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cell culture; Demyelination; Oligodendroglia; Spinal cord injury

Indexed keywords

ANIMAL CELL; ARTICLE; ASTROCYTE; BRAIN CORTEX; CELL CULTURE; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CELL STRUCTURE; GLIA CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; NEWBORN; NONHUMAN; OLIGODENDROCYTE PRECURSOR CELL; OLIGODENDROGLIA; PHASE CONTRAST MICROSCOPY; RAT; SCANNING ELECTRON MICROSCOPY; STEM CELL;

ANIMALS; ANIMALS, NEWBORN; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; NEURAL STEM CELLS; OLIGODENDROGLIA; RATS; RATS, SPRAGUE-DAWLEY; STEM CELLS;

EID: 79959745958     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/1743132810Y.0000000024     Document Type: Article

References (25)

1. Sekhon LH, Fehlings MG. Epidemiology, demographics, and pathophysiology of acute spinal cord injury. Spine 2001;26:S2-12.
2. Totoiu MO, Keirstead HS. Spinal cord injury is accompanied by chronic progressive demyelination. J Comp Neurol 2005;486:373-83.
3. Kövari E, Gold G, Herrmann FR, Canuto A, Hof PR, Michel JP, et al. Cortical microinfarcts and demyelination significantly affect cognition in brain aging. Stroke 2004;35:410-4.
4. Davis KL, Stewart DG, Friedman JI, Buchsbaum M, Harvey PD, Hof PR, et al. White matter changes in schizophrenia: evidence for myelin-related dysfunction. Arch Gen Psychiatry 2003;60:443-56.
5. Kakulas BA. The applied neuropathology of human spinal cord injury. Spinal Cord 1999;37:79-88.
6. Waxman SG. Axon-glia interactions: building a smart nerve fiber. Curr Biol 1997;7:R406-10.
7. Griffiths I, Klugmann M, Anderson T, Yool D, Thomson C, Schwab MH, et al. Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science 1998;280: 1610-3.
8. Hulsebosch CE. Recent advances in pathophysiology and treatment of spinal cord injury. Advan Physiol Educ 2002; 26:238-55.
9. Warden P, Bamber NI, Li H, Esposito A, Ahmad KA, Hsu CY, et al. Delayed glial cell death following wallerian degeneration in white matter tracts after spinal cord dorsal column cordotomy in adult rats. Exp Neurol 2000;168:213-24.
10. Xu GY, Hughes MG, Ye Z, Hulsebosch CE, McAdoo DJ. Concentrations of glutamate released following spinal cord injury kill oligodendrocytes in the spinal cord. Exp Neurol 2004;187:329-36.
11. Casha S, Yu WR, Fehlings MG. Oligodendroglial apoptosis occurs along degenerating axons and is associated with FAS and p75 expression following spinal cord injury in the rat. Neuroscience 2001;103:203-18.
12. Small RK, Riddle P, Noble M. Evidence for migration of oligodendrocyte-type-2 astrocyte progenitor cells into the developing rat optic nerve. Nature 1987;328:155-7.
13. Temple S, Raff MC. Clonal analysis of oligodendrocyte development in culture: evidence for a developmental clock that counts cell divisions. Cell 1986;44:773-9.
14. Kocsis JD, Akiyama Y, Lankford KL, Radtke C. Cell transplantation of peripheral-myelin-forming cells to repair the injured spinal cord. J Rehabil Res Dev 2002;39:287-98.
15. Barnett SC, Riddell JS. Olfactory ensheathing cell transplantation as a strategy for spinal cord repair-what can it achieve? Nat Clin Pract Neurol 2007;3:152-61.
16. Morgan DM. Tetrazolium (MTT) assay for cellular viability and activity. Methods Mol Biol 1998;79:179-83.
17. McDonald JW, Belegu V. Demyelination and remyelination after spinal cord injury. J Neurotrauma 2006;23:345-59.
18. Utzschneider DA, Archer DR, Kocsis JD, Waxman SG, Duncan ID. Transplantation of glial cells enhances action potential conduction of amyelinated spinal cord axons in the myelin-deficient rat. Proc Natl Acad Sci USA 1994;91:53-7.
19. Papastefanaki F, Chen J, Lavdas AA, Thomaidou D, Schachner M, Matsas R. Grafts of Schwann cells engineered to express PSA-NCAM promote functional recovery after spinal cord injury. Brain 2007;130:2159-74.
20. Baumann N, Pham-Dinh D. Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev 2001;81:871-927.
21. McCarthy KD, de Vellis J. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 1980;85:890-902.
22. Myckatyn TM, Mackinnon SE, McDonald JW. Stem cell transplantation and other novel techniques for promoting recovery from spinal cord injury. Transpl Immunol 2004;12:343-58.
23. Jones SA, Jolson DM, Cuta KK, Mariash CN, Anderson GW. Triiodothyronine is a survival factor for developing oligodendrocytes. Mol Cell Endocrinol 2003;199:49-60.
24. Gu J, Royland JE, Wiggins RC, Konat GW. Selenium is required for normal upregulation of myelin genes in differentiating oligodendrocytes. J Neurosci Res 1997;47: 626-35.
25. Bögler O, Wren D, Barnett SC, Land H, Noble M. Cooperation between two growth factors promotes extended self-renewal and inhibits differentiation of oligodendrocyte-type-2 astrocyte (O-2A) progenitor cells. Proc Natl Acad Sci USA 1990;87:6368-72.